Skip to content

Determining the effect of Ketemine on the treatment resistant depression

Determining the effect of intravenous Ketemine on the severity of symptoms of treatment resistant depression

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210806052096N1
Enrollment
62
Registered
2022-04-09
Start date
2022-04-04
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder. Major depressive disorder, recurrent, unspecified

Interventions

Intervention 1: Intervention group: Patients aged 25 to 60 years who were diagnosed with major depressive disorder based on the DSM-V criteria and did not respond to at least 2 antidepressants, receiv

Sponsors

Zanjan University of Medical Sciences
Lead Sponsor
Vice Chancellor for Research, Zanjan University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Diagnosis of major depressive disorder based on DSMV criteria Failure to respond to at least 2 antidepressants with sufficient therapeutic dose The criterion of Montgomery-Asberg at least 25

Exclusion criteria

Exclusion criteria: Having skull masses Having history of HTN Having history of IHD Having a recent or past psychotic disorder Consumption of recent substances Pregnancy Existence of unstable medical disease

Design outcomes

Primary

MeasureTime frame
Depression severity based on Montgomery-Asberg. Timepoint: Before injecting the drug-Immediately after drug injection-1 hour after drug injection-4 hour after drug injection-1 day after drug injection-3 day after drug injection-7 day after drug injection-1 month after drug injection-2 month after drug injection. Method of measurement: Based on Montgomery-Asberg questionnaire.

Secondary

MeasureTime frame
Suicide idea. Timepoint: Before the drug injection-after the drug injection. Method of measurement: Based on the Beck questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarnaz Taherkhani

Zanjan University of Medical Sciences

taherkhanifarnaz71@gmail.com+98 24 3354 4001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026